Myelos Corporation
Records under this name other than patents Myelos Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,524,818 | Prosaposin as a Neurotrophic Factor No holder on record Term ended Term ended Jul 20, 2016 · Medium confidence | Term ended | Term ended Jul 20, 2016 | Medium confidence |
| US 8,063,016 | Retro-inverso peptides derived from interleukin-6 Lapsed on the fee record Ended Nov 22, 2015 · USPTO record | Lapsed on the fee record | Ended Nov 22, 2015 | USPTO record |
| US 6,590,074 | Prosaposin receptor Lapsed on the fee record Ended Jul 8, 2015 · USPTO record | Lapsed on the fee record | Ended Jul 8, 2015 | USPTO record |
| US 7,135,461 | Retro-inverso peptides derived from interleukin-6 Lapsed on the fee record Ended Nov 14, 2014 · USPTO record | Lapsed on the fee record | Ended Nov 14, 2014 | USPTO record |
| US 7,115,571 | Retro-inverso peptides derived from interleukin-3 Lapsed on the fee record Ended Oct 3, 2014 · USPTO record | Lapsed on the fee record | Ended Oct 3, 2014 | USPTO record |
| US 6,458,357 | Retro-inverso neurotrophic and analgesic peptides Lapsed on the fee record Ended Oct 1, 2014 · USPTO record | Lapsed on the fee record | Ended Oct 1, 2014 | USPTO record |
| US 7,109,168 | Retro-inverso peptides derived from leukemia inhibitory factor Lapsed on the fee record Ended Sep 19, 2014 · USPTO record | Lapsed on the fee record | Ended Sep 19, 2014 | USPTO record |
| US 7,754,688 | Methods of using retro-inverso peptides derived from interleukin-6 Lapsed on the fee record Ended Jul 13, 2014 · USPTO record | Lapsed on the fee record | Ended Jul 13, 2014 | USPTO record |
| US 7,754,690 | Method of using retro inverso peptides derived from leukemia inhibitory factor Lapsed on the fee record Ended Jul 13, 2014 · USPTO record | Lapsed on the fee record | Ended Jul 13, 2014 | USPTO record |
| US 6,559,124 | Use of prosaposin and peptides obtained therefrom for treatment of neural degeneration Term ended Ended no later than Jul 30, 2013 · USPTO record | Term ended | Ended no later than Jul 30, 2013 | USPTO record |